Congratulations to Balfron High School
That the Parliament congratulates everyone at Balfron High School on it being selected by the Commonwealth Games Organising Committee to nominate a pupil representative to take part in the Queen’s Baton Relay ahead of the 2014 Glasgow Commonwealth Games; believes that this achievement is a result of the work of both the school and its pupils in recent years in promoting sport and team playing; considers that Balfron High will choose a deserved candidate to take part in what it sees as this historic event, and wishes the school the best of luck.
International Day of Medical Physics
That the Parliament welcomes the first-ever International Day of Medical Physics on 7 November 2013; recognises what it sees as the valuable role played by those professionals engaged in this field in the NHS in Scotland, and considers that, with the growing use of radiotherapy and investigations involving emissions, their role is expanding and that this international recognition is overdue.
Genetic Testing for Prostate Cancer
That the Parliament recognises the Movember campaign, which highlights the significant mortality rate from prostate cancer and the difficulty in predicting which early cancers require radical intervention as opposed to watchful waiting; acknowledges what it considers the inadequacy of Prostate Specific Antigen (PSA) as a predictive or screening tool; welcomes the research by a UK/US team, led by Dan Berney, on CCP Score, which it considers is a novel genetic test for prostate cancer; notes that the team has developed an expression signature composed of 31 cell cycle progressions and 15 housekeeper genes; understands that an expression score (Prolaris score) was derived as the mean of all cell cycle progression genes and that the signature was tested at disease diagnosis in two conservatively managed cohorts (N=337 and 349) after radical prostatectomy in two cohorts from the United States (N=366 and 413) and after external beam radiation therapy (N=141); notes that all studies were retrospective; understands that the CCP signature was a highly significant predictor of outcome in all five studies; also understands that, in conservatively managed patients, the Prolaris score was the dominant variable for predicting death from prostate cancer; believes that, in all five studies, the HR per unit change in the Prolaris score was remarkably similar, ranging from 1.89 to 2.92, indicating that the effect size for the Prolaris score is robust in terms of clinical setting and patient composition, and hopes that what it considers this innovative tool will now be examined further in prospective studies.